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Background: The burden of healthcare-associated infections, such as healthcare-acquired
Clostridium difficile (HA-CDI), can be expressed in terms of additional length of stay (LOS)
and mortality. However, previous estimates have varied widely. Although some have
considered time of infection onset (time-dependent bias), none considered the impact of
severity of HA-CDI; this was the primary aim of this study.
Methods: The daily risk of in-hospital death or discharge was modelled using a Cox pro-
portional hazards model, fitted to data on patients discharged in 2012 from a large English
teaching hospital. We treated HA-CDI status as a time-dependent variable and adjusted for
confounders. In addition, a multi-state model was developed to provide a clinically
intuitive metric of delayed discharge associated with non-severe and severe HA-CDI
respectively.
Findings: Data comprised 157 (including 48 severe) HA-CDI cases among 42,618 patients.
HA-CDI reduced the daily discharge rate by nearly one-quarter [hazard ratio (HR): 0.72;
95% confidence interval (CI): 0.61e0.84] and increased the in-hospital death rate by 75%
compared with non-HA-CDI patients (HR: 1.75; 95% CI: 1.16e2.62). Whereas overall HA-CDI
resulted in a mean excess LOS of about seven days (95% CI: 3.5e10.9), severe cases had an
average excess LOS which was twice (w11.6 days; 95% CI: 3.6e19.6) that of the non-
severe cases (about five days; 95% CI: 1.1e9.5).
Conclusion: HA-CDI contributes to patients’ expected LOS and risk of mortality. However,
when quantifying the health and economic burden of hospital-onset of HA-CDI, the het-
erogeneity in the impact of HA-CDI should be accounted for.
ª 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.School of Hygiene and
1E 7HT, UK. Tel.: þ44 (0)
.uk (E. van Kleef).
ociety. Published by ElsevierIntroduction
Clostridium difficile is a considerable cause of healthcare-
associated infections in Europe and the USA.1,2 In common
with other healthcare-associated infections, patients with
healthcare-associated Clostridium difficile infection (HA-CDI)Ltd. All rights reserved.
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system. Previous economic analyses of HA-CDI have shown that
direct healthcare, and opportunity, costs due to excess length of
hospital stay (LOS) were the main HA-CDI cost drivers.3e6 How-
ever, a recent review of publications on HA-CDI-associated
additional hospital stay showed wide variation in excess LOS,
ranging from 2.8 to 16.1 days.7 These studies primarily used
simple regression models, which did not account for the timing
of onset of infection (‘time-dependent bias’).8 Hence, they may
overestimate the duration of excess hospitalization, as a longer
stay in hospital may increase the risk of infection. This has been
demonstrated rigorously for other healthcare-associated in-
fections but has rarely been explicitly explored for HA-CDI.7e10
Two recent publications, which implicitly adjusted for time-
dependent bias, reported very different results.11,12 Using a
Cox proportional hazards model, Forster et al. concluded that
HA-CDI patients had a median excess LOS of six days, whereas
Mitchell et al. found no significant impact of HA-CDI on hospital
stay.11,12 Mitchell et al. used multi-state modelling (MSM),
which e in addition to appropriately adjusting for both time to
event bias and the competing end-points related to nosocomial
infections, namely discharge and death e also provided more
easily interpretable results than the proportional hazards
model.11 In their conclusion, Mitchell et al. posit that their
results, and the difference from earlier estimates, could
potentially be explained by milder HA-CDI due to a lack of
circulating hypervirulent polymerase chain reaction (PCR)
ribotype 027 in their locality (Tasmania, Australia).
As the clinical presentation of HA-CDI can range from mild
diarrhoea to pseudomembranous colitis and even death, and
the prevalence of severe HA-CDI can vary regionally, due to
differences in ribotype prevalence and case-mix, it is impor-
tant for any estimation of attributable LOS and mortality to
consider these heterogeneities.13e16 In this study, we investi-
gate the effect of severe infection on the expected delayed
discharge and mortality associated with HA-CDI based on a Cox
proportional hazards model as well as MSM techniques.Methods
Data
Data were collected from Guy’s and St Thomas’ National
Health Service (NHS) Foundation Trust, a teaching hospital
including two sites with w1200 beds. Details of all inpatients
discharged in 2012 (namely: age, primary diagnosis code, dates
of admission and discharge, and discharge status; i.e. discharge
alive or death) were extracted from the Trust’s electronic pa-
tient record database. These data were linked to the Trust’s
voluntarily collected HA-CDI surveillance database containing
information on date of onset of symptoms, markers of HA-CDI
severity, antibiotic treatment, and, where known, the ribo-
type that caused the infection. In order to evaluate only those
infections that were hospital-acquired, patients with symptom
onset 48 h after admission and all patients with LOS 48 h
were excluded from analyses.Severe HA-CDI
Severe HA-CDI was defined by the clinical presence of one or
more of four indicators: (i) peripheral white blood cell count>15  109/L; (ii) acutely rising serum creatinine (>50% in-
crease above baseline); (iii) temperature >38.5C; or (iv)
radiographic evidence of colitis or endoscopic appearance of
pseudomembranous colitis.17Procedure
Proportions and medians were compared using the c2-test
and ManneWhitneyeWilcoxon test, respectively. A Cox pro-
portional hazards model was used to estimate the impact of
HA-CDI on the risk of hospital discharge alive or death. This
method can adjust for time-dependent bias and take into ac-
count the impact of important non-healthcare-associated
infection variables such as age and comorbidity score on LOS.
Hence, the method can identify and adjust for important
confounders. Nonetheless, it does not produce an easily
interpretable metric (namely hazard ratios) for economic
analysis. Therefore we constructed a suitable MSM, to quantify
the average excess LOS caused by the event of interest, i.e.
HA-CDI. However, using established methodology, MSM does
not account for the potential confounding effect of other
variables. As an alternative, we stratified our data by each of
the relevant confounders, and performed the MSM on these
subsamples.Statistical analysis
Cox regression model
The risk of in-hospital death or discharge was modelled with
a Cox proportional hazards model, with HA-CDI treated as a
time-dependent risk factor. We added the covariates age and
comorbidity to assess their confounding effects on the risk of
in-hospital death or discharge. Comorbidity was expressed in a
Charlson Comorbidity Index (CCI) score based on the patients’
primary diagnosis code.18 These primary diagnoses were clas-
sified using International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10) codes.18
Multi-state model
The first MSM comprised four states; admission with no HA-
CDI (state 0), HA-CDI (state 1), discharge alive (state 2), and
death in hospital (state 3).19 Since we were solely concerned
with HA-CDI, it was assumed that all patients were admitted to
the hospital without infection. Uninfected patients remained
in state 0 from admission until discharge (state 2) or in-hospital
death (state 3). Infected patients entered state 1 and then
remained in that state until discharge or death. This competing
end-points approach allowed for assessment of the impact of
mortality due to HA-CDI on patients’ expected excess stay, e.g.
whether HA-CDI-related mortality may shorten expected LOS.
Second, prolonged LOS associated with HA-CDI was estimated
by constructing an MSM in which the two competing end-points
were combined as a single state.20 Transitions between states
were determined by time-varying hazards, which were esti-
mated using the AaleneJohansen estimator.21 For each point in
time t (in days), the expected LOS for HA-CDI and non-infected
patients was compared. The unadjusted expected change in
LOS was then calculated as the average difference in LOS of
HA-CDI and non-HA-CDI cases across all days, weighted relative
to the frequency of the possible events (i.e. HA-CDI, discharge
alive and in-hospital death) on each day.22 Bootstrapping was
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intervals.23
To assess the effect of specific confounders identified by the
Cox regression model, the MSM compared patients within their
risk group by stratification, for each potential confounding
variable separately. To evaluate the effect of severe HA-CDI on
excess LOS, a stratified analysis was conducted, comparing
mean differences in LOS of non-severe HA-CDI and severe HA-
CDI cases respectively to non-infected patients.
All analyses were performed with R 3.0.1 (Team R Devel-
opment Core: http://cran.r-project.org/). The R-packages
mvna and etm were used to estimate the excess LOS and
standard errors, and the R-package ‘survival’ was used for the
Cox model.21,24
Results
Descriptive statistics
The data comprised a total sample of 42,618 patients; 157
(0.4%) had an episode of HA-CDI, of which 48 (30.6%) were
severe (Table I). The median age of the infected patients was
72 years [interquartile range (IQR): 57e82], which was signifi-
cantly higher than the median age of non-infected patients (47
years; IQR: 26e68; P < 0.0001). The vast majority of all pa-
tients had no reported comorbidities (91.6%, 39,146 patients).
This percentage was slightly lower in the HA-CDI-infected pa-
tient group (84.7%, 133 patients) than in the non-infected
group (91.9%, 39,013 patients; P ¼ 0.002). On average, pa-
tients with severe HA-CDI had spent a shorter time in hospital
until identification of the infection than non-severe cases
(Table I). Moreover, after detection, the median LOS was
longer for severely infected patients (Table I). Finally, the
causative PCR ribotypes were known for 113 (72.0%) of the HA-
CDI patients. None of these patients had an infection caused by
hypervirulent PCR ribotype 027.
Cox regression model results
HA-CDI-positive patients had a lower daily chance of being
discharged (alive or dead) than non-infected patients
(Table II). Both age of the patient (i.e. >65 or <65 years), and
the patient’s comorbidity were significant confounders, and
the adjusted daily hazard of discharge (hazard ratio: HR) forTable I
Demographic characteristics of the Guy’s and St Thomas’ hospital pati
Variable Non-infected
(N ¼ 42,461)
Infected (N ¼ 157) N
Age >65 years 13,446 (31.7%) 102 (65.0%)
CCI score
0 39,013 (91.9%) 133 (84.7%)
1 3448 (8.1%) 24 (15.3%)
Death 801 (1.9%) 24 (15.3%)
Length of staya 4.0/7.6 (2.0e8.0) 25.0/36.6 (15.0e50.0) 29.
Length of stay
pre infectiona
NA 9.0/15.8 (4.0e18.0) 10.
Length of stay
post infectiona
NA 12.0/21.1 (6.0e25.0) 11.
HA-CDI, healthcare-associated Clostridium difficile infection; CCI, Charlso
a Median/mean (interquartile range).HA-CDI patients was 0.72 [95% confidence interval (CI):
0.61e0.84] (Table II). Moreover, HA-CDI patients were at higher
risk of experiencing in-hospital death than HA-CDI-negative
patients (HR: 1.75; 95% CI: 1.16e2.62). Accounting for
severity of the infection revealed that both non-severe and
severe cases had a significantly reduced daily likelihood of
discharge compared to non-infected cases, with a further
reduction for the severe CDI group (Table II, Figure 1). How-
ever, severe infection did not result in a further elevated
chance of dying in hospital (Table II).
Multi-state model results
The four-state multi-state model, which allowed for
competing end-points, and the three-state combined end-point
model yielded similar estimates for the excess LOS. Thus mor-
tality due to HA-CDI did not seem to have an impact on the
estimated additional days of hospitalization associated with HA-
CDI. For this reason, only the outcomes of the combined end-
point model are presented. The average extra number of days
(unadjusted for confounders) spent inhospital due toHA-CDIwas
about seven days (95% CI: 4e11) (Table II). Patients with severe
HA-CDI had, on average, twice the additional LOS of non-severe
cases, but with overlapping confidence intervals (Table II).
Stratification of our sample by age and comorbidity score still
showed an impact of HA-CDI on the patients’ stay. AmongHA-CDI
patients aged <65 years (55 in total), there was an average
excess LOS of about seven days (95% CI: 1e14) associated with
HA-CDI; for patients aged>65 years (133 in total) this was about
six days (95% CI: 2e11). A sample restricted to patients with a
comorbidity score <1 (133 patients) showed an excess LOS of
about seven days (95% CI: 3e11) whereas an average excess LOS
ofw10 days (95% CI:1 to 21) associatedwith HA-CDIwas found
for patients with a score of >1 (24 patients).
Discussion
This study showed that HA-CDI resulted in a prolonged LOS of
about seven days. Moreover, the daily mortality rate of HA-CDI
patients was almost twice that of non-HA-CDI-infected pa-
tients, as has been suggested elsewhere.26 Severe infection
increased the average expected excess LOS associated with HA-
CDI.Our LOS estimates are comparable to themedian additional
six days estimated by a Canadian study, which also adjusted forents discharged in 2012
on-severe HA-CDI
(N ¼ 109)
Severe HA-CDI
(N ¼ 48)
Total
(N ¼ 42,618)
73 (67.0%) 29 (60.4%) 13,548 (31.8%)
96 (88.1%) 37 (77.1%) 39,146 (91.9%)
13 (11.9%) 11 (22.9%) 3472 (8.1%)
15 (13.8%) 9 (18.7%) 825 (1.9%)
0/36.6 (15.0e50.0) 22.5/36.8 (14.8e44.8) 4.0/7.7 (2.0e8.0)
0/17.1 (4.0e22.0) 7.0/12.1 (3.8e12.3) NA
0/19.5 (6.0e24.0) 13.5/24.6 (7.8e27.8) NA
n Comorbidity Index; NA, not applicable.
Table II
Hazard ratios for in-hospital death or discharge alive and excess length of stay estimated from the Cox regression model and multi-state
model
Exposure Hazard ratio (95% CI) for
discharge alivea
Hazard ratio (95% CI) for
in-hospital deatha
Hazard ratio (95% CI) for
discharge alive or deatha
Excess LOS
(95% CI)d
Time-adjustedb Fully adjustedc Time-adjustedb Fully adjustedc Time-adjustedb Fully adjustedc
All CDI 0.66 (0.56e0.77) 0.72 (0.61e0.84) 1.98 (1.33e2.96) 1.75 (1.16e2.62) 0.73 (0.64e0.84) 0.79 (0.69e0.92) 7.2 (3.5e10.9)
Severe CDI 0.53 (0.39e0.71) 0.59 (0.44e0.79) 2.11 (1.17e3.79) 1.76 (0.95e3.25) 0.62 (0.49e0.76) 0.69 (0.54e0.85) 11.6 (3.6e19.6)
Non-severe
CDI
0.73 (0.60e0.88) 0.79 (0.66e0.96) 1.91 (1.13e3.22) 1.74 (1.03e2.93) 0.80 (0.67e0.95) 0.86 (0.71e1.03) 5.3 (1.1e9.5)
CI, confidence interval; LOS, length of hospital stay; CDI, Clostridium difficile infection.
To estimate the hazard ratios for discharge alive and in-hospital death respectively, the observations on patients who experienced a competing risk
event were censored, i.e. removed from the risk set used for the hazard calculation at time of occurrence of the event, based on the principles of
the cause-specific hazard function.25
a Cox regression model.
b Cox regression model with time to infection included as a time-dependent variable.
c Cox regression model with time to infection included as a time-dependent variable, and age (<65 and >65 years) and comorbidity (Charlson
Comorbidity Index score <1 and 1) included as covariates.
d Multi-state model.
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the findings of a recent study by Mitchell et al. in an Australian
hospital using a comparableMSM, suggesting that HA-CDI did not
result in excess LOS.7,12 As the MSM of Mitchell et al. did not
implicitly adjust for such potential confounders, difference in
case-mix among the different hospital settings (UK and
Australia) could have been responsible for the differences in
measured excess LOS.27 However, stratifiedMSM results (by age,
and comorbidity index score respectively) revealed that both
younger and older HA-CDI patients had an increased average
LOS of about six or seven days, and patients of both comorbidity0 5 10 15 20 25 30 35 40 45 50
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Figure 1. KaplaneMeier curve for the time-adjusted length of hosp
difficile infection (HA-CDI) (solid line), non-severe HA-CDI (dashed line
(i.e. death).groups had an increased expected LOS related to CDI, so this is
unlikely to supply the explanation. Moreover, the non-severe
HA-CDI patients in our sample still had a significantly
increased LOS of about five days; thus, even the potential lack
of severely infected patients in the Australian sample would
have most likely resulted in an effect on LOS. However, with
only three published studies using appropriate methods, little
can be concluded with regard to the heterogeneity in the
findings. More appropriate analyses of existing datasets (e.g.
those reviewed by Mitchell et al.) might be a sensible way
forward.755 60 65 70 8075 85 90 95 100
n hospital
ital stay for patients without healthcare-associated Clostridium
), and severe HA-CDI (dotted line). þ denote censored observations
E. van Kleef et al. / Journal of Hospital Infection 88 (2014) 213e217 217Our dataset was collected as part of routine record keeping
in a large teaching hospital, which led to a number of limita-
tions in our study. First, the number of patients with HA-CDI
was small, resulting in relatively large standard errors for the
risk-group-stratified MSM analysis. A larger dataset would have
allowed sufficient power to sub-stratify the analysis further.
Second, the comorbidity index was calculated using only the
primary diagnosis code of each patient, as more detailed in-
formation was not available to the researchers. Therefore, our
analysis might not have fully adjusted for the effect of
concomitant conditions. Finally, patients who spend a longer
time in hospital are at increased risk of acquiring healthcare-
associated infections other than HA-CDI, which could have
extended their LOS rather than HA-CDI. However, considering
the construction of the MSM, this may be explained as follows:
HA-CDI-positive patients who were in hospital for a given
number of days post onset were compared to admitted HA-CDI-
negative patients still in hospital after this number of days.
Thus, both these populations were arguably equally at risk of
acquiring healthcare-associated infections other than HA-CDI.
In conclusion, the present work confirms the heterogeneity
among patients concerning the health and economic burden of
CDI. To our knowledge, these results have yielded the first
severity-specific estimate of the additional LOS and excess
mortality due to CDI. We believe that the techniques presented
here could supply policy-makers e locally, nationally, and
regionally e with an estimate of the burden of CDI for their
patient population and severity of CDI.
Conflict of interest statement
None declared.
Funding sources
This work was supported by the Healthcare Infection
Society Grant: Modelling the population-level effect and
cost-effectiveness of C. difficile vaccination as part of an
integrated healthcare and associated infection prevention
and control strategy.
References
1. Bauer MP, Notermans DW, van Benthem BHB, et al. Clostridium
difficile infection in Europe: a hospital-based survey. Lancet
2011;377(9759):63e73.
2. Kuijper EJ, Coignard B, Tu¨ll P. Emergence of Clostridium diffi-
cile-associated disease in North America and Europe. In:
Kuijper EJ, Coignard B, Tull P, editors. Clin Microbiol Infect
2006;12. 2e18.
3. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the
healthcare system. Clin Infect Dis 2012;55:S88eS92.
4. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short-
and long-term attributable costs of Clostridium difficile-associ-
ated disease in nonsurgical inpatients. Clin Infect Dis
2008;46:497e504.
5. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of
Clostridium difficile. Clin Microbiol Infect 2012;18:282e289.
6. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic
healthcare costs of Clostridium difficile infection: a systematic
review. J Hosp Infect 2010;74:309e318.
7. Mitchell BG, Gardner A. Prolongation of length of stay and Clos-
tridium difficile infection: a review of the methods used to
examine length of stay due to healthcare associated infections.
Antimicrob Resist Infect Control 2012;1:14.8. Van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent
bias was common in survival analyses published in leading clinical
journals. J Clin Epidemiol 2004;57:672e682.
9. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N,
Wolkewitz M. The time-dependent bias and its effect on extra
length of stay due to nosocomial infection. Value Health
2011;14:381e386.
10. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B.
Estimating the cost of health care-associated infections: mind your
p’s and q’s. Clin Infect Dis 2010;50:1017e1021.
11. Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N. The
prolongation of length of stay because of Clostridium difficile
infection. Am J Infect Control 2014;42:164e167.
12. Forster AJ, Taljaard M, Oake N, Wilson KW, Roth V, van
Walraven C. The effect of hospital-acquired infection with Clos-
tridium difficile on length of stay in hospital. Can Med Assoc J
2012;184:17e18.
13. Wilcox MH, Shetty N, Fawley WN, et al. Changing epidemiology of
Clostridium difficile infection following the introduction of a na-
tional ribotyping-based surveillance scheme in England. Clin
Infect Dis 2012;55:1056e1063.
14. Walker AS, Eyre DW, Wyllie DH, et al. Relationship between
bacterial strain type, host biomarkers, and mortality in Clos-
tridium difficile infection. Clin Infect Dis 2013;56:1589e1600.
15. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clos-
tridium difficile infection due to a new hypervirulent strain,
polymerase chain reaction ribotype 078. Clin Infect Dis 2008;
47:1162e1170.
16. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors
for severe Clostridium difficile-associated disease. Emerg Infect
Dis 2009;15:415e422.
17. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical
Microbiology and Infectious Diseases: update of the treatment
guidance document for Clostridium difficile infection. Clin
Microbiol Infect 2014;20:1e26.
18. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H,
Ghali WA. New ICD-10 version of the Charlson comorbidity index
predicted in-hospital mortality. J Clin Epidemiol 2004;57:
1288e1294.
19. Beyersmann J, Wolkewitz M, Allignol A, Grambauer N,
Schumacher M. Application of multistate models in hospital
epidemiology: advances and challenges. Biom J 2011;53:
332e350.
20. Angelis G de, Allignol A, Murthy A, et al. Multistate modelling to
estimate the excess length of stay associated with meticillin-
resistant Staphylococcus aureus colonisation and infection in
surgical patients. J Hosp Infect 2011;78:86e91.
21. Allignol A, Schumacher M, Beyersmann J. Empirical transition
matrix of multi-state models: the etm package. J Stat Softw
2011;38:1e15.
22. Schulgen G, Schumacher M. Estimation of prolongation of hospital
stay attributable to nosocomial infections: new approaches based
on multistate models. Lifetime Data Anal 1996;2:219e240.
23. Davison AC, Hinkley DV. Bootstrap methods and their application.
New York: Cambridge University Press; 1997.
24. Jackson CH. Multistate models for panel data. J Stat Softw
2011;38(8).
25. Lau B, Cole SR, Gange SJ. Competing risk regression models for
epidemiologic data. Am J Epidemiol 2009;170:244e256.
26. Hensgens MPM, Goorhuis A, Dekkers OM, van Benthem BHB,
Kuijper EJ. All-cause and disease-specific mortality in hospitalized
patients with Clostridium difficile infection: a multicenter cohort
study. Clin Infect Dis 2013;56:1108e1116.
27. Louie TJ, Miller MA, Crook DW, Lentnek A. Effect of age on
treatment outcomes in Clostridium difficile infection. J Am Ger-
iatr Soc 2013;61:222e230.
